Skip to main content

Advertisement

Fig. 3 | BMC Cancer

Fig. 3

From: CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis

Fig. 3

Concentrations of biomarkers in EC plasma samples depending on FIGO stage. a CD44 (t(3) = 16.10, p = 0.001, post-hoc p < 0.05). b EpCAM (t(3) = 12.06, p = 0.007, post-hoc p < 0.05). c Mesothelin (t(2) = 6.15, p = 0.046, post-hoc p < 0.05). d TGM2 (t(3) = 26.04, p < 0.001, post-hoc p < 0.05). * p < 0.05, ** p < 0.01, *** p < 0.001

Back to article page